Method for treating Alzheimer's disease using glial line-derived

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 21, A61F 200, A61K 4700, A61K 31685, A61K 3800

Patent

active

057312842

ABSTRACT:
The present invention relates generally to methods for treating injury or degeneration of basal forebrain cholinergic neurons by administering glial cell line-derived neurotrophic factor (GDNF). The invention relates specifically to methods for treating Alzheimer's disease.

REFERENCES:
patent: 4518584 (1985-05-01), Mark et al.
patent: 4892538 (1990-01-01), Aebischer et al.
patent: 5011472 (1991-04-01), Aebischer et al.
patent: 5106627 (1992-04-01), Aebischer et al.
patent: 5252714 (1993-10-01), Harris et al.
patent: 5639275 (1997-06-01), Baelge et al.
patent: 5641749 (1997-06-01), Yan et al.
patent: 5641750 (1997-06-01), Louis
Varon et al., (1979) Ann. Rev. Neurosci., 1:327-361.
Thoenen et al., (1985) Science, 229:238-242.
Thoenen et al., (1991) Trends Neurosci., 14:165-170.
Lapchak et al., (1993) Rev. Neurosci., 3:1-10.
Bothwell, (1995) Ann. Rev. Neurosci., 18:223-253.
Chao, (1995) TINS, 18:321-326.
Venero et al., (1993) Neuroreport 4:959-962.
Hefti, (1994) J. Neurobiol. 25:1418-1435.
Olson, (1994) Neurochem. Jul. 15:1-3.
Batchelor et al., (1989) J. Comp. Neurol. 284:187-204.
Kiss et al., (1988) Neurosci. 27:731-748.
Woolf et al., (1989) Neurosci. 30:143-152.
Lin et al., (1993) Science 260:1130-1132.
Krieglstein et al., (1995) EMBO J. 14:736-742.
Poulsen et al., (1994) Neuron 13:1245-1252.
Hudson et al., (1995) Brain Res. Bull. 36:425-432.
Beck et al., (1995) Nature 373:339-341.
Tomac et al., (1995) Nature 373:335-339.
Hoffer et al., (1994) Neurosci. Lett. 182:107-111.
Oppenheim et al., (1995) Nature 373:344-346.
Zurn et al., (1994) Neuroreport 6:113-118.
Yan et al., (1995) Nature 373:341-344.
Henderson et al., (1994) Science 266:1062-1064.
Miller et al., (1994) Soc. Neurosci. Abstr. 20:1300.
Selkoe, (1991) Neuron. 6:487-498.
Gage et al., (1986) Neurosci. 19:241-255.
Hagg et al., (1989) Brain Res. 505:29-38.
Hefti, (1986) J. Neurosci. 6:2155-2162.
Springer et al., (1987) J. Neurosci. Res. 17:111-118.
Sofroniew et al., (1993) J. Neurosci. 13:5263-5276.
Knusel et al., (1992) J. Neurosci. 12:4391-4402.
Koliatsos et al., (1994) J. Comp. Neurol. 343:247-262.
Koliatsos et al., (1991) Ann. Neurol. 30:831-840.
Morse et al., (1993) J. Neurosci. 13:4146-4156.
Venero et al., (1994) Neurosci. 59:797-815.
Widmer et al., (1993) Neuroreport 4:363-366.
Williams et al., (1989) Brain Res. 498:243-256.
Williams et al., (1986) Proc. Natl. Acad. Sci. USA 83:9231-9235.
Phelps et al., (1989) Neurobiol. Aging 10:205-207.
Olson, (1994) Neurochem. Jul. 25:1-3.
Olson et al., (1992) J. Neural Transm. 4:79-95.
Petty et al., (1994) Ann. Aug. 36:244-246.
Hagg et al., (1989) Neurosci. 30:95-103.
Rylett et al., (1993) J. Neurosci. 13:3956-3963.
Lapchak, (1993) Exp. Neurol. 124:16-20.
Butcher et al., (1989) Neurobiol. Aging 10:557-570.
Woolf et al., (1994) Neurosci. Sep. 62:327-331.
Della Seta er al., (1994) Pharmacol. 49:701-705.
Lewin et al., (1993) Trends Neurosci. Sep. 16:353-359.
Williams et al. (1991) Exp. Neurol. 113:31-37.
Hefti et al., (1993) Adv. Pharmacol. 24:239-273.
Fischer et al., (1994) Proc. Natl. Acad. Sci. USA 91:8607-8611.
Schmidt-Kastner et al., (1994) Mol. Brain Res. 26:325-330.
Schaar et al., (1993) Exp. Neurol. 124:368-371.
Schaar et al., (1994) Exp. Neurol. 130:387-393.
Dayhoff, (1972) Atlas of Protein Sequence and Structure 5:124.
Cunningham et al., (1989) Science 244:1081-1085.
Malik et al., (1992) Exp. Hematol. 20:1028-1035.
Francis, (1992) Focus on Growth Factors 3(2):4-10.
Chamow et al., (1994) Bioconjugate Chem. 5:133-140.
Winn et al., (1991) Exper. Neurol. 113:322-329.
Aebischer et al., (1991) Exper. Neurol. 111:269-275.
Tresco et al., (1992) ASAIO 38:17-23.
Kearns et al., (1995) Brain Res., 672:104-111.
Stromberg et al., (1995) Exp. Neurol. 124:401-412.
Schrier et al., (1967) Neurochem. 14:977-985.
Smolen, Ed. Conn, (1990) Neurosciences 3:208-229.
Emmett et al., (1995) Brain Res. 673:199-207.
Alderson, (1995) Eur. J. Neurosci.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for treating Alzheimer's disease using glial line-derived does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treating Alzheimer's disease using glial line-derived, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating Alzheimer's disease using glial line-derived will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2288951

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.